Clinical Trials Directory

Trials / Completed

CompletedNCT01131715

Pharmacist Follow-up, a Qualitative Study of Patient Experience

Pharmacist Follow-up of Patients With Coronary Heart Disease. A Qualitative Study of Patient Experience.

Status
Completed
Phase
Study type
Observational
Enrollment
4 (actual)
Sponsor
Hospital Pharmacy of North Norway Trust · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

A pharmacist follow-up procedure is under development. Patients with coronary heart disease (CHD) is being followed up by a pharmacist for one year with three meetings; at discharge from hospital, after three months and after one year. The evaluation is basically based on quantitative measures as achievement of therapeutic goals, number of drug related problems detected, hospitalisations etc. However, the patients' own experience with the follow-up procedure cannot be evaluated using these measures. Thus, a qualitative approach is needed. In this study, a total of four patients participating in the follow-up will be included and interviewed. A semistructured interview guide will be used. Interviews will be taped, transcribed and analyzed with the intention to explore how patients experience the follow-up from the pharmacist. A thoruough content analysis will be performed. Patients included must have met the pharmacist at least twice. The pharmacist in charge of the follow-up will recruit patients and hand out study information. Patients will reply to the principal investigator of the study and thus kept anonymous for the pharmacist in charge of the follow-up. No pressure will be put on the patients to join, but it will be emphasized that it will help evaluating the procedure.

Detailed description

See full publication on http://www.biomedcentral.com/1756-0500/7/197 Garcia et al. BMC Research Notes 2014, 7:197

Conditions

Timeline

Start date
2010-02-01
Primary completion
2010-03-01
Completion
2012-07-01
First posted
2010-05-27
Last updated
2020-06-29

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT01131715. Inclusion in this directory is not an endorsement.